Impaired bone marrow homing of cytokine-activated CD34+ cells in the NOD/SCID model

被引:51
作者
Ahmed, F
Ings, SJ
Pizzey, AR
Blundell, MP
Thrasher, AJ
T Ye, H
Fahey, A
Linch, DC
Yong, KL
机构
[1] UCL Royal Free & Univ Coll Med Sch, Dept Haematol, London WC1E 6HX, England
[2] UCL Royal Free & Univ Coll Med Sch, Dept Histopathol, London WC1E 6HX, England
[3] Inst Child Hlth, Mol Immunol Unit, London, England
[4] Guangxi Med Univ, Dept Pathol, Guangxi, Peoples R China
关键词
D O I
10.1182/blood-2003-06-1770
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The reduced engraftment potential of hematopoietic stem/progenitor cells (HSPCs) after exposure to cytokines may be related to the impaired homing ability of actively cycling cells. We tested this hypothesis by quantifying the short-term homing of human adult Cb34(+) cells in nonobese diabetic/severe combined immunodeficient (NOD/SCID) animals. We show that the loss of engraftment ability of cytokine-aciivated CD34(+) cells is associated with a reduction in homing of colony-forming cells (CFCs) to bone marrow (BM) at 24 hours after transplantation (from median 2.6% [range, 1.9%-6.1%] to 0.3% [0.0%6-0.7%]; n = 3; P < .01), coincident with an increase in CFC accumulation in the lungs (P < .01). Impaired BM homing of cytokine-activated cells was not restored by using sorted cells in G(0)G(1) or by inducing cell cycle arrest at the G(1)/S border. Blocking Fas ligation in vivo did not increase the BM homing of cultured cells. Finally, we tested cytokine combinations or culture conditions previously reported to restore the engraftment of cultured cells but did not find that any of these was able to reverse the changes in homing behavior of cytokine-exposed cells. We suggest that these changes in homing and, as a consequence, engraftment result from the increased migratory capacity of infused activated cells, leading to the loss of selectivity of the homing process. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:2079 / 2087
页数:9
相关论文
共 41 条
[31]   Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: Implications for stem cell frequency assessment [J].
van Hennik, PB ;
de Koning, AE ;
Ploemacher, RE .
BLOOD, 1999, 94 (09) :3055-3061
[32]   MARROW-SEEDING AND SPLEEN-SEEDING EFFICIENCIES OF ALL MURINE HEMATOPOIETIC STEM-CELL SUBSETS ARE DECREASED BY PREINCUBATION WITH HEMATOPOIETIC GROWTH-FACTORS [J].
VANDERLOO, JCM ;
PLOEMACHER, RE .
BLOOD, 1995, 85 (09) :2598-2606
[33]   Increased migration of cord blood-derived CD34+ cells, as compared to bone marrow and mobilized peripheral blood CD34+ cells across uncoated or fibronectin-coated filters [J].
Voermans, C ;
Gerritsen, WR ;
Borne, AEGKV ;
van der Schoot, CE .
EXPERIMENTAL HEMATOLOGY, 1999, 27 (12) :1806-1814
[34]   Variable product purity and functional capacity after CD34 selection:: a direct comparison of the CliniMACS® (v2•1) and Isolex® 300i (v2•5) clinical scale devices [J].
Watts, MJ ;
Somervaille, TCP ;
Ings, SJ ;
Ahmed, F ;
Khwaja, A ;
Yong, K ;
Linch, DC .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (01) :117-123
[35]   Modulation of hematopoietic stem/progenitor cell engraftment by transforming growth factor β [J].
Wiesmann, A ;
Kim, M ;
Georgelas, A ;
Searles, AE ;
Cooper, DD ;
Green, WF ;
Spangrude, GJ .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (02) :128-139
[36]  
Wilpshaar J, 2000, BLOOD, V96, P2100
[37]   Engraftment potential of human fetal hematopoietic cells in NOD/SCID mice is not restricted to mitotically quiescent cells [J].
Wilpshaar, J ;
Bhatia, M ;
Kanhai, HHH ;
Breese, R ;
Heilman, DK ;
Johnson, CS ;
Falkenburg, JHF ;
Srour, EF .
BLOOD, 2002, 100 (01) :120-127
[38]   Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells [J].
Yonemura, Y ;
Ku, H ;
Hirayama, F ;
Souza, LM ;
Ogawa, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) :4040-4044
[39]   Influence of cell cycling and cell division on transendothelial migration of CD34+ cells [J].
Yong, KL ;
Fahey, A ;
Pizzey, A ;
Linch, DC .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (02) :500-509
[40]   Transmigration of CD34+ cells across specialized and nonspecialized endothelium requires prior activation by growth factors and is mediated by PECAM-1 (CD31) [J].
Yong, KL ;
Watts, M ;
Thomas, NS ;
Sullivan, A ;
Ings, S ;
Linch, DC .
BLOOD, 1998, 91 (04) :1196-1205